Finance
Some roundup plaintiffs seek to delay preliminary approval of proposed $7.25 billion bayer settlement, court filing shows
Published by Global Banking & Finance Review®
Posted on February 25, 2026
1 min readLast updated: February 25, 2026
Quick Summary
On Feb. 25, 2026, lawyers for nearly 20,000 Roundup plaintiffs asked a Missouri judge to delay preliminary approval of Bayer’s $7.25B settlement, arguing a March 4 review would violate cancer patients’ due‑process rights.
Bayer Roundup Plaintiffs Urge Delay of $7.25B Settlement Preliminary Review
Roundup Settlement Review Faces Organized Pushback
Feb 25 (Reuters) - Law firms representing nearly 20,000 people who sued Bayer over alleged injuries from its Roundup weedkiller urged a Missouri judge on Wednesday to delay reviewing the German company’s proposed $7.25 billion nationwide settlement, arguing that rushing would violate the rights of tens of thousands of cancer patients and their families.
Why Plaintiffs Want More Time
In a filing in a state court in St Louis, the firms said the accord should not be fast-tracked for possible preliminary approval on March 4, fifteen days after the proposed settlement was announced.
Key Hearing Date and Timing
The request is the first major organized pushback against Bayer’s attempt to resolve most of the 65,000 remaining Roundup claims in state and federal courts.
March 4 Preliminary Approval Target
Scope of Remaining Roundup Claims
(Reporting by Diana Novak Jones in Chicago, Editing by Alexia Garamfalvi)
Key Takeaways
- •Law firms for nearly 20,000 plaintiffs asked a Missouri judge to delay preliminary approval.
- •The proposal at issue is Bayer’s nationwide $7.25B Roundup settlement.
- •The filing argues a rushed process would harm cancer patients’ due‑process rights.
- •Preliminary approval was set for March 4, 2026, just 15 days after the deal was announced.
- •The accord aims to resolve most of roughly 65,000 remaining Roundup claims.
Frequently Asked Questions about Some roundup plaintiffs seek to delay preliminary approval of proposed $7.25 billion bayer settlement, court filing shows
1What is the main topic?
Plaintiffs’ lawyers asked a Missouri judge to delay preliminary approval of Bayer’s proposed $7.25 billion Roundup settlement, citing due‑process concerns for cancer patients and families.
2When was the review scheduled and why seek a delay?
Preliminary approval was slated for March 4, 2026. Opponents say fast‑tracking the deal—only 15 days after it was announced—could undermine class members’ rights to review and object.
3How many claims could the settlement address?
The agreement is intended to resolve most of the roughly 65,000 remaining Roundup claims in U.S. courts, though participation and court approval are still required.
